RVPH

Reviva Pharmaceuticals Stock Price

4.12
0.29 (7.57%)
Upgrade to Real-Time
Regular Market
4.12

Low
3.66

52 Week Range

High
9.61

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Reviva Pharmaceuticals Holdings Inc RVPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.29 7.57% 4.12 12:09:05
Open Price Low Price High Price Close Price Prev Close
3.96 3.96 4.30 3.83
Bid Price Ask Price Spread News
4.12 4.21 0.09 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
329 61,768 $ 4.20 $ 259,384 - 3.66 - 9.61
Last Trade Time Type Quantity Stock Price Currency
12:09:05 100 $ 4.12 USD

Period:

Draw Mode:

Reviva Pharmaceuticals Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 21.15M 5.13M 6.68M $ - $ - -0.04 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Reviva Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RVPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.914.303.663.8162,3000.215.37%
1 Month5.005.19993.664.3249,163-0.88-17.6%
3 Months5.776.073.665.04124,931-1.65-28.6%
6 Months8.909.503.668.28807,432-4.78-53.71%
1 Year9.469.613.668.28664,169-5.34-56.45%
3 Years9.469.613.668.28664,169-5.34-56.45%
5 Years9.469.613.668.28664,169-5.34-56.45%

Reviva Pharmaceuticals Description

Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis.


Your Recent History
NASDAQ
RVPH
Reviva Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.